M. Andreuccetti

2.5k total citations · 1 hit paper
28 papers, 1.8k citations indexed

About

M. Andreuccetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, M. Andreuccetti has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in M. Andreuccetti's work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (12 papers) and Gastric Cancer Management and Outcomes (6 papers). M. Andreuccetti is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (12 papers) and Gastric Cancer Management and Outcomes (6 papers). M. Andreuccetti collaborates with scholars based in Italy, United States and France. M. Andreuccetti's co-authors include Alfredo Falcone, Gianluca Masi, I. Brunetti, Cristina Granetto, Giacomo Allegrini, Enrico Cortesi, Sergio Ricci, Cinzia Orlandini, Luisa Fioretto and Lucio Crinò and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Annals of Surgery.

In The Last Decade

M. Andreuccetti

28 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

2007 872 citations Alfredo Falcone, Sergio Ricci et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Andreuccetti Italy	14	1.5k	841	563	374	209	28	1.8k
R. Adam France	11	1.7k 1.1×	946 1.1×	489 0.9×	568 1.5×	220 1.1×	29	2.1k
E. Pfanner Italy	12	1.3k 0.9×	674 0.8×	470 0.8×	347 0.9×	187 0.9×	28	1.5k
G. Wilson United Kingdom	16	1.5k 1.0×	309 0.4×	749 1.3×	344 0.9×	207 1.0×	34	1.9k
José María Viéitez Spain	14	1.1k 0.7×	290 0.3×	563 1.0×	132 0.4×	219 1.0×	52	1.4k
H. Kröning Germany	13	1.0k 0.7×	231 0.3×	592 1.1×	254 0.7×	179 0.9×	26	1.5k
Janja Ocvirk Slovenia	17	1.0k 0.7×	226 0.3×	376 0.7×	231 0.6×	156 0.7×	69	1.3k
Nobuyuki Mizunuma Japan	23	1.5k 1.0×	327 0.4×	530 0.9×	259 0.7×	506 2.4×	133	2.0k
Per‐Ebbe Jönsson Sweden	20	927 0.6×	341 0.4×	434 0.8×	348 0.9×	239 1.1×	35	1.5k
Emmanuel Achille France	12	2.5k 1.7×	936 1.1×	931 1.7×	670 1.8×	292 1.4×	27	3.0k
Eugenio Marcuello Spain	17	1.4k 0.9×	227 0.3×	385 0.7×	451 1.2×	233 1.1×	33	1.6k

Countries citing papers authored by M. Andreuccetti

Since Specialization

Citations

This map shows the geographic impact of M. Andreuccetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Andreuccetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Andreuccetti more than expected).

Fields of papers citing papers by M. Andreuccetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Andreuccetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Andreuccetti. The network helps show where M. Andreuccetti may publish in the future.

Co-authorship network of co-authors of M. Andreuccetti

This figure shows the co-authorship network connecting the top 25 collaborators of M. Andreuccetti. A scholar is included among the top collaborators of M. Andreuccetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Andreuccetti. M. Andreuccetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masi, Gianluca, Fotios Loupakis, Lisa Salvatore, et al.. (2010). Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. The Lancet Oncology. 11(9). 845–852. 190 indexed citations

Masi, Gianluca, Fotios Loupakis, Lorenzo Fornaro, et al.. (2010). Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis. JNCI Journal of the National Cancer Institute. 103(1). 21–30. 137 indexed citations

Loupakis, Fotios, Gianluca Masi, Lorenzo Fornaro, et al.. (2010). Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma. Cancer Chemotherapy and Pharmacology. 66(3). 559–566. 5 indexed citations

Vasile, Enrico, Laura Ginocchi, Carmelo Tibaldi, et al.. (2010). Second-line Treatment for Non–Small-Cell Lung Cancer: One Size Does Not Fit All. Clinical Lung Cancer. 11(5). 320–327. 12 indexed citations

Masi, Gianluca, Fotios Loupakis, Luca Emanuele Pollina, et al.. (2009). Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases. Annals of Surgery. 249(3). 420–425. 165 indexed citations

Vasile, Enrico, Gianluca Masi, Lorenzo Fornaro, et al.. (2009). A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer. British Journal of Cancer. 100(11). 1720–1724. 31 indexed citations

Masi, Gianluca, Enrico Vasile, Fotios Loupakis, et al.. (2009). Bevacizumab (BV) in combination with folfoxiri (Irinotecan, Oxaliplatin and Infusional 5FU/LV) as first-line treatment of metastatic colorectal cancer (mCRC): a phase II trial by the GONO GROUP. CINECA IRIS Institutial research information system (University of Pisa). 20. 2 indexed citations

Tibaldi, Carmelo, Enrico Vasile, Ilaria Bernardini, et al.. (2008). Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model. Journal of Cancer Research and Clinical Oncology. 134(10). 1143–1149. 56 indexed citations

Tibaldi, Carmelo, Enrico Vasile, Andrea Antonuzzo, et al.. (2008). First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study. British Journal of Cancer. 98(3). 558–563. 8 indexed citations

10.

Galli, Luca, Andrea Fontana, C. Galli, et al.. (2007). Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer. British Journal of Cancer. 97(12). 1613–1617. 4 indexed citations

11.

Falcone, Alfredo, Sergio Ricci, I. Brunetti, et al.. (2007). Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest. Journal of Clinical Oncology. 25(13). 1670–1676. 872 indexed citations breakdown →

12.

Falcone, Alfredo, M. Andreuccetti, I. Brunetti, et al.. (2007). Updated results, multivariate and subgroups analysis confirm improved activity and efficacy for FOLFOXIRI versus FOLFIRI in the G.O.N.O. randomized phase III study in metastatic colorectal cancer (MCRC). Journal of Clinical Oncology. 25(18_suppl). 4026–4026. 4 indexed citations

13.

Masi, Gianluca, Lorenzo Marcucci, Fotios Loupakis, et al.. (2006). First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer. Annals of Oncology. 17(8). 1249–1254. 21 indexed citations

14.

Masi, Gianluca, Giacomo Allegrini, Samanta Cupini, et al.. (2004). First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule. Annals of Oncology. 15(12). 1766–1772. 93 indexed citations

15.

Chibbaro, Salvatore, et al.. (2004). Temozolomide as First-Line Agent in Treating High-Grade Gliomas: Phase II Study. Journal of Neuro-Oncology. 67(1-2). 77–81. 32 indexed citations

16.

Falcone, Alfredo, Gianluca Masi, Samanta Cupini, et al.. (2004). Surgical resection of metastases (mts) after biweekly chemotherapy with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI) in initially unresectable metastatic colorectal cancer (MCRC). Journal of Clinical Oncology. 22(14_suppl). 3553–3553. 11 indexed citations

17.

Falcone, Alfredo, Monica Lencioni, I. Brunetti, et al.. (1997). Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Annals of Oncology. 8(6). 539–545. 20 indexed citations

18.

Andreuccetti, M., Giacomo Allegrini, Andrea Antonuzzo, et al.. (1996). Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: In vitro synergistic cytotoxicity and dna-induced strand-breaks. European Journal of Cancer. 32(7). 1219–1226. 24 indexed citations

19.

Paolicchi, Aldo, Michela Saviozzi, Simona Piaggi, et al.. (1996). Localization of a GSH-Dependent Dehydroascorbate Reductase in Rat Tissues and Subcellular Fractions. Archives of Biochemistry and Biophysics. 333(2). 489–495. 49 indexed citations

20.

Falcone, Alfredo, Romano Danesi, Lucia Zaccaro, et al.. (1994). Synergistic antiproliferative activity of suramin and α2A-interferon against human colorectal adenocarcinoma cell lines: In vitro studies. European Journal of Cancer. 30(4). 516–520. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact